Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Dr Lal Pathlabs has informed that it has submitted the disclosure of material impact of COVID-19 pandemic on the business and operations of the Company.
The above information is a part of company’s filings submitted to BSE.